Cargando…
Current and Emerging Treatments for Multiple Myeloma
BACKGROUND: The prognosis and treatment of multiple myeloma (MM) has evolved greatly over the past decade. The development and incorporation of new agents such as immunomodulators and proteasome inhibitors into therapy has improved outcomes and is helping patients enjoy longer periods of remission....
Autores principales: | Schwartz, Rowena N., Vozniak, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437421/ https://www.ncbi.nlm.nih.gov/pubmed/18774881 http://dx.doi.org/10.18553/jmcp.2008.14.S7-A.12 |
Ejemplares similares
-
Introduction: Multiple Myeloma
por: Cook, Richard
Publicado: (2008) -
Pathophysiological Underpinnings of Multiple Myeloma Progression
por: Jagannath, Sungar
Publicado: (2008) -
Economic and Clinical Impact of Multiple Myeloma to Managed Care
por: Cook, Richard
Publicado: (2008) -
Multiple Myeloma: Supportive Care Requirements and Coordination of Patient-Centered Care
por: Bugos, Kelly G., et al.
Publicado: (2012) -
Applying Oncology Formulary and Benefit Design Innovations to the Management of Multiple Myeloma in the Managed Care Setting
por: Mullins, C. Daniel
Publicado: (2012)